| Report ID | 281670 |
| Drug Identification Number | 02243676 |
| Brand name | RECOMBIVAX HB |
| Common or Proper name | (hepatitis B vaccine [recombinant]) |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HEPATITIS B SURFACE ANTIGEN |
| Strength(s) | 10MCG |
| Dosage form(s) | SUSPENSION SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 10MCG/1ML 1DOSE |
| ATC code | J07BC |
| ATC description | VIRAL VACCINES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2026-04-24 |
| Actual discontinuation date | 2026-04-14 |
| Remaining supply date | 2026-04-24 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | RECOMBIVAX HB® (10 mcg/mL) vials will be discontinued and replaced by RECOMBIVAX HB® (10 mcg/mL) pre-filled syringes |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 [email protected] |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2026-04-14 | French | Compare |
| v7 | 2026-04-14 | English | Compare |
| v6 | 2026-04-13 | French | Compare |
| v5 | 2026-04-13 | English | Compare |
| v4 | 2026-04-01 | French | Compare |
| v3 | 2026-04-01 | English | Compare |
| v2 | 2026-03-27 | French | Compare |
| v1 | 2026-03-27 | English | Compare |
Showing 1 to 8 of 8